+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East & Africa Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis

  • PDF Icon

    Report

  • 106 Pages
  • July 2023
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 5888004
The Middle East & Africa cardiopulmonary oxygenator market was valued at US$ 30.74 million in 2022 and is expected to reach US$ 35.49 million by 2028. It is estimated to register a CAGR of 2.4% from 2022 to 2028

Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients Middle East & Africa Cardiopulmonary Oxygenator Market

Congenital heart defects are among the most common birth defects affecting populations worldwide. Pediatric membrane oxygenator devices have been developed with efforts made over a long period to assist in the treatment of these defects. After cardiac surgical procedures, numerous pediatric patients have experienced improved clinical outcomes in the quality of life and survival rate. For achieving this, pediatric membrane oxygenators are used in conjunction with the heart-lung machine, which assists in the repair of most congenital cardiac defects. Thus, oxygenators have become an important part of modern pediatric cardiac surgical setting that supports whole-body perfusion.

In 2022, Burjeel Medical City in Abu Dhabi announced that the launch of the Extracorporeal Membrane Oxygenation (ECMO) life support system for pediatric patients. Burjeel Medical City will select a few hospitals in the UAE that offers life support systems for children and neonates. Further, Lilliput is a range of open-system oxygenators offered by the company for supporting pediatric patients during cardiac pulmonary bypass.

With continued research and development and the introduction of extracorporeal membrane oxygenation (ECMO) devices, companies in the cardiopulmonary oxygenator market have managed to address complications regarding the incidence of air embolism, hemolysis, blood-to-water interface reactions, and other adverse events. In November 2022, Fresenius Medical Care’s heart & lung division - Xenios AG - introduced the MiniLung petite kit, which is specially designed for neonatal and pediatric ECMO. The kit is meant to offer respiratory or cardiopulmonary life support by enabling extracorporeal circulation and physiological gas exchange in the blood.

The ECMO treatment can help save the lives of critically ill patients, especially newborns, infants, or children suffering from severe cardiopulmonary diseases. Thus, the research and development for improvements in ECMO provide opportunities for companies in the cardiopulmonary oxygenator market.

Middle East & Africa Cardiopulmonary Oxygenator Market Overview

The Middle East & Africa cardiopulmonary oxygenator market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to account for the largest market share and is expected to develop moderately in the Middle East & Africa. Countries such as UAE and South Arabia are expected to be the largest contributor to the cardiopulmonary oxygenator market due to the large population and rising prevalence of respiratory disorders such as asthma, COPD, chronic rhinosinusitis, allergies, and others as well as cardiovascular disorders is expected to boost the market growth.

According to a study conducted by Cleveland Clinic Abu Dhabi, more than half of the residents in UAE have been affected by heart disease during their lifespan. Cardiovascular disease is the prime cause of death in the UAE, with symptoms in patients often occurring a decade earlier than their counterparts in other developed nations. According to an article published by PLOS ONE, CVD contributes to 40% of all deaths and its incidence is increasing in young adults mainly because of an increase in the burden of its known risk factors such as abdominal obesity (71.5%), dyslipidemia (74.0%), hypertension (43.0%), and diabetes (32.4%).

South Africa has growing incidences of chronic respiratory diseases, such as COPD and asthma. Also, the healthcare facilities in South Africa are developing and adopting the latest technologies to offer better treatments and diagnoses. COPD and other respiratory diseases such as asthma and pneumonia significantly burden South Africa's health system. The Burden of Obstructive Lung Disease (BOLD) study, conducted to determine the prevalence of COPD globally, found an overall prevalence of 7.7% in Nigeria and 19% in South Africa. Unlike other chronic diseases, COPD mortality for both men and women are increasing. COPD is the only chronic disease showing a progressive upward trend in death rates and illness. The COPD burden is projected to increase in the coming decades because of continued exposure to smoking and the rise in the aging population. Moreover, with the COVID-19 pandemic, the need for these devices has increased locally.

Exhibit: Middle East & Africa Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Cardiopulmonary Oxygenator Market Segmentation

The Middle East & Africa Cardiopulmonary Oxygenator Market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.

Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.

Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.

Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

Based on country, the market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the market share in 2022.

Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Microport Scientific Corp; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the cardiopulmonary oxygenator market in the region.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Cardiopulmonary Oxygenator Market - by Product
1.3.2 Middle East & Africa Cardiopulmonary Oxygenator Market - by Application
1.3.3 Middle East & Africa Cardiopulmonary Oxygenator Market - by Type
1.3.4 Middle East & Africa Cardiopulmonary Oxygenator Market - by Age Group
1.3.5 Middle East & Africa Cardiopulmonary Oxygenator Market - by End Use
1.3.6 Middle East & Africa Cardiopulmonary Oxygenator Market - by Geography
2. Middle East & Africa Cardiopulmonary Oxygenator Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Cardiopulmonary Oxygenator Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Middle East & Africa Cardiopulmonary Oxygenators Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Incidence of Cardiopulmonary Diseases
5.1.2 Increasing Surgical Procedures with Surging in Aging Population
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients
5.4 Future Trends
5.4.1 Use of Portable Extracorporeal Membrane Oxygenation in Lung Transplant Procedures
5.5 Impact Analysis
6. Cardiopulmonary Oxygenators Market - Middle East & Africa Analysis
6.1 Middle East & Africa Cardiopulmonary Oxygenators Market Revenue Forecast and Analysis
7. Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product
7.1 Overview
7.2 Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Membrane Oxygenator
7.3.1 Overview
7.3.2 Membrane Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Bubble Oxygenator
7.4.1 Overview
7.4.2 Bubble Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application
8.1 Overview
8.2 Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
8.3 Cardiac
8.3.1 Overview
8.3.2 Cardiac: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.3 Acute myocardial infarction
8.3.4 Overview
8.3.5 Acute myocardial infarction: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.6 Myocarditis
8.3.7 Overview
8.3.8 Myocarditis: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.9 Post-transplant complication
8.3.10 Overview
8.3.11 Post-transplant complication: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.12 Decompensated Cardiomyopathy
8.3.13 Overview
8.3.14 Decompensated Cardiomyopathy: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.3.15 Others
8.3.16 Overview
8.3.17 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory
8.4.1 Overview
8.4.2 Respiratory: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.3 Respiratory Failure
8.4.4 Overview
8.4.5 Respiratory Failure: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.6 Acute Respiratory Distress Syndrome
8.4.7 Overview
8.4.8 Acute Respiratory Distress Syndrome: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.9 Pulmonary Embolism
8.4.10 Overview
8.4.11 Pulmonary Embolism: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.12 Pneumonia
8.4.13 Overview
8.4.14 Pneumonia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8.4.15 COVID-19
8.4.16 Overview
8.4.17 COVID-19: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type
9.1 Overview
9.2 Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
9.3 Reusable Oxygenator
9.3.1 Overview
9.3.2 Reusable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Disposable Oxygenator
9.4.1 Overview
9.4.2 Disposable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group
10.1 Overview
10.2 Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
10.3 Adults
10.3.1 Overview
10.3.2 Adults: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Pediatric
10.4.1 Overview
10.4.2 Pediatric: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Neonates
10.5.1 Overview
10.5.2 Neonates: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
11. Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use
11.1 Overview
11.2 Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
11.3 Hospitals and Clinics
11.3.1 Overview
11.3.2 Hospitals and Clinics: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
11.4 Ambulatory Surgical Centers
11.4.1 Overview
11.4.2 Ambulatory Surgical Centers: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12. Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis
12.1 Middle East & Africa Cardiopulmonary Oxygenators Market
12.1.1 Overview
12.1.2 Middle East & Africa: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
12.1.2.1 Saudi Arabia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 Overview
12.1.2.1.2 Saudi Arabia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 Saudi Arabia: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.1.4 Saudi Arabia: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.1.4.1 Saudi Arabia: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.1.4.2 Saudi Arabia: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.1.5 Saudi Arabia: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.1.6 Saudi Arabia: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.1.7 Saudi Arabia: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
12.1.2.2 UAE: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.1 Overview
12.1.2.2.2 UAE: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 UAE: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.2.4 UAE: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.2.4.1 UAE: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.2.4.2 UAE: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.2.5 UAE: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.2.6 UAE: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.2.7 UAE: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
12.1.2.3 South Africa: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.1 Overview
12.1.2.3.2 South Africa: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 South Africa: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.3.4 South Africa: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.3.4.1 South Africa: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.3.4.2 South Africa: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.3.5 South Africa: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.3.6 South Africa: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.3.7 South Africa: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
12.1.2.4 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.1 Overview
12.1.2.4.2 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.3 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
12.1.2.4.4 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
12.1.2.4.4.1 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
12.1.2.4.4.2 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
12.1.2.4.5 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
12.1.2.4.6 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
12.1.2.4.7 Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
13. Middle East & Africa Cardiopulmonary Oxygenators Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies in Cardiopulmonary Oxygenator Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 LivaNova Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Medtronic Plc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Terumo Corp
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 MicroPort Scientific Corp
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.6 Chalice Medical Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Fresenius Medical Care AG & Co KGaA
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
15. Appendix
15.1 About The Publisher
15.2 Glossary of Terms
List of Tables
Table 1. Saudi Arabia Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 2. Saudi Arabia Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 3. Saudi Arabia Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 4. Saudi Arabia Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 5. Saudi Arabia Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 6. Saudi Arabia Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 7. Saudi Arabia Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 8. UAE Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 9. UAE Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 10. UAE Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 11. UAE Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 12. UAE Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 13. UAE Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 14. UAE Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 15. South Africa Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 16. South Africa Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 17. South Africa Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 18. South Africa Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
Table 19. South Africa Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 20. South Africa Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 21. South Africa Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 22. Rest of Middle East & Africa Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
Table 23. Rest of Middle East & Africa Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
Table 24. Rest of Middle East & Africa Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
Table 25. Rest of Middle East & Africa Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 ( USD Million)
Table 26. Rest of Middle East & Africa Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
Table 27. Rest of Middle East & Africa Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
Table 28. Rest of Middle East & Africa Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
Table 29. Recent Organic Growth Strategies in Middle East & Africa Cardiopulmonary Oxygenator Market
Table 30. Recent Inorganic Growth Strategies in The Middle East & Africa Cardiopulmonary Oxygenator Market
Table 31. Glossary of Terms
List of Figure
Figure 1. Middle East & Africa Cardiopulmonary Oxygenator Market Segmentation
Figure 2. Middle East & Africa Cardiopulmonary Oxygenator Market, by region
Figure 3. Middle East & Africa Cardiopulmonary Oxygenator Market Overview
Figure 4. Membrane Oxygenator Segment Held Largest Share of Product Segment in Cardiopulmonary Oxygenator Market
Figure 5. Saudi Arabia Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Middle East & Africa Experts’ Opinion
Figure 8. Middle East & Africa Cardiopulmonary Oxygenators Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Middle East & Africa Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
Figure 11. Membrane Oxygenator: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Bubble Oxygenator: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Middle East & Africa Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
Figure 14. Cardiac: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Acute myocardial infarction: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Myocarditis: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Post-transplant Complication: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Decompensated Cardiomyopathy: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Respiratory: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Respiratory Failure: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Acute Respiratory Distress Syndrome: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Pulmonary Embolism: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pneumonia: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. COVID-19: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Middle East & Africa Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
Figure 27. Reusable Oxygenator: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Disposable Oxygenator: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Middle East & Africa Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
Figure 30. Adults: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Pediatric: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Neonates: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Middle East & Africa Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
Figure 34. Hospitals and Clinics: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Ambulatory Surgical Centers: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others: Middle East & Africa Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Middle East & Africa: Cardiopulmonary Oxygenators Market, by Key Country - Revenue (2021) (US$ Million)
Figure 38. Saudi Arabia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. UAE: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. South Africa: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Rest of Middle East & Africa: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Middle East & Africa Growth Strategies in Cardiopulmonary Oxygenator Market

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • Terumo Corp
  • Microport Scientific Corp
  • Chalice Medical Ltd
  • Fresenius Medical Care AG & Co KGaA

Table Information